Evaluation and Management of Microscopic Hematuria in Female Patients

Initial Assessment and Risk Stratification

The American Academy of Family Physicians recommends confirming the presence of true microscopic hematuria with microscopic examination, as dipstick testing alone is insufficient due to limited specificity (65-99%) 3, 1
The American Urological Association defines microscopic hematuria as ≥3 RBC per high-power field on microscopic evaluation of urinary sediment from two of three properly collected specimens 3, 1
The American College of Physicians recommends excluding benign causes of hematuria, including menstruation, vigorous exercise, sexual activity, viral illness, trauma, and urinary tract infection, before further evaluation 2, 4
Risk factors for significant urologic disease include age >40 years, smoking history, occupational exposure to chemicals or dyes, history of gross hematuria, previous urologic disorder or disease, history of irritative voiding symptoms, history of recurrent urinary tract infection, analgesic abuse, and history of pelvic irradiation 2, 5

The American Academy of Family Physicians recommends examining urinary sediment for dysmorphic red blood cells and red cell casts to differentiate glomerular from non-glomerular bleeding 5, 2
Glomerular bleeding is suggested by >80% dysmorphic RBCs, while lower urinary tract bleeding is suggested by >80% normal (doughnut-shaped) RBCs 5, 2
The National Kidney Foundation recommends assessing for proteinuria and measuring serum creatinine to evaluate for glomerular disease 5, 2
The American Society of Nephrology recommends considering glomerular source if significant proteinuria (>500 mg/24 hours), dysmorphic RBCs (>80%), red cell casts, or elevated serum creatinine are present 5, 2

For suspected glomerular bleeding (renal disease), the American Society of Nephrology recommends referral to nephrology, especially if proteinuria exceeds 500 mg/24 hours, red cell casts or predominantly dysmorphic RBCs are present, or elevated serum creatinine is present 5, 2
For suspected non-glomerular bleeding without benign cause, the American Urological Association recommends risk-stratifying the patient based on age, risk factors, and RBC count, and managing accordingly 1, 2, 6
The American College of Radiology recommends using CT urography as the preferred imaging modality for high-risk patients 6

The American Heart Association recommends evaluating patients on anticoagulants the same way as patients not on these agents, as they have similar malignancy risk 1, 6
The American College of Physicians recommends not assuming that microscopic hematuria in women is due to menstruation without verification through repeat testing after menstruation 4
The prevalence of microscopic hematuria varies from 0.19% to 21%, with higher rates in older populations, according to the American Academy of Family Physicians 3
While microscopic hematuria has a lower risk of malignancy (2.6-4%) compared to gross hematuria (30-40%), it still requires thorough evaluation, according to the American Urological Association 4